Oncology Letters (2022)
PMID: 36039056
DOI: 10.3892/ol.2022.13455
AUTHORS
Yang Wang1,Wenying Xia2,Fangrong Shen3,Jinhua Zhou3,Yanzheng Gu3,Youguo Chen3AFFILIATIONS
1Department of Obstetrics and Gynecology, Nanjing Drum Tower Hospital Group Suqian Hospital and The Affiliated Suqian Hospital of Xuzhou Medical University, Suqian, Jiangsu 223800, P.R. China
2Department of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210000, P.R. China
3Department of Obstetrics and Gynecology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, P.R. China
Author response
16 day ago
#1Mycosphaerella Arachidis
An image is shared between two papers and labelled as showing different cell lines. In most cases I would give the earlier paper the priority, but in this case both papers have parts of the image not found in the other, presumably each had access to a larger image, so this can't be seen as a simple case of plagiarism.
I think it would be to the benefit of both teams of authors to figure out what's happened here.
Identified by ImageTwin.ai, the other paper can be found here.
#2Youguo Chen (author)
16 day ago
Following meticulous inspection of the experimental records and images from that period, it has been determined that the repetition of images was due to the misuse of experimental pictures. The researchers in our group, while drafting this section, inadvertently used images from experiments conducted by another research group with whom we had previously collaborated. We are prepared to reorganize the images and make the necessary corrections to this section.
#3Hoya Camphorifolia
15 day ago
experiments conducted by another research group with whom we had previously collaborated
Did any publications come out of this collaboration? The authors of the other paper do not seem to be aware of it.
#4Hoya Camphorifolia
15 day ago
[left] Fig 2A.
[right] Fig 3A from "DNA methylation mediated silencing of microRNA-145 is a potential prognostic marker in patients with lung adenocarcinoma" (Xia et al 2015).
